At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

In early 2021, individual investors and institutions hurled money at Moderna stock as if future growth were unlimited.

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

Under normal circumstances, the study of health problems after COVID vaccinations posted online on Feb. 25 might not have ...

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

The Trump administration is at risk of its first major failure as the measles outbreak spreads. Donald G. McNeil Jr., a ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...